NME3
Nucleoside diphosphate kinase 3
Also known as: DR-nm23, NDK3_HUMAN, NDPKC, NM23-H3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13232
- Gene
- NME3
- Ensembl
- ENSG00000103024
- Chromosome
- 16
- Canonical length
- 169 aa
- Protein class
- Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Secretome location
- Intracellular and membrane
- Quaternary structure
- Homohexamer
OverviewNCBI Gene
Enables nucleoside diphosphate kinase activity. Involved in DNA repair; mitochondrial fusion; and nucleoside triphosphate biosynthetic process. Located in mitochondrial outer membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
169 residues, UniProt reviewed canonical sequence.
>Q13232|NME3
1 MICLVLTIFA NLFPAACTGA HERTFLAVKP DGVQRRLVGE IVRRFERKGF KLVALKLVQA
61 SEELLREHYA ELRERPFYGR LVKYMASGPV VAMVWQGLDV VRTSRALIGA TNPADAPPGT
121 IRGDFCIEVG KNLIHGSDSV ESARREIALW FRADELLCWE DSAGHWLYELocalizationUniProt · AlphaFold · HPA
Whether an antibody against NME3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 106 nTPM
Expression across tissuesHPA
Tissue
- adrenal gland: 106 nTPM
- pituitary gland: 93 nTPM
- cerebellum: 84 nTPM
- basal ganglia: 81 nTPM
- prostate: 80 nTPM
- amygdala: 75 nTPM
Single-cell type
- breast lactating cells: 277 nCPM
- epididymal efferent duct absorptive cells: 207 nCPM
- epididymal basal cells: 178 nCPM
- breast myoepithelial cells: 168 nCPM
- breast hormone-responsive cells: 156 nCPM
- decidual stromal cells: 145 nCPM
Immune cell
- plasmacytoid DC: 87 nTPM
- non-classical monocyte: 66 nTPM
- classical monocyte: 62 nTPM
- intermediate monocyte: 61 nTPM
- memory CD4 T-cell: 56 nTPM
- myeloid DC: 54 nTPM
Brain region
- white matter: 50 nTPM
- medulla oblongata: 48 nTPM
- thalamus: 46 nTPM
- spinal cord: 45 nTPM
- midbrain: 44 nTPM
- basal ganglia: 44 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.95
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.69
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- CTP biosynthetic process
- DNA repair
- dTTP biosynthetic process
- GTP biosynthetic process
- mitochondrial fusion
- nucleoside triphosphate biosynthetic process
- protein hexamerization
- UTP biosynthetic process
- mitochondrial outer membrane fusion
Molecular functions
- ADP binding
- ATP binding
- cAMP binding
- GDP binding
- metal ion binding
- mitochondrion-mitochondrion outer membrane tether activity
- nucleoside diphosphate kinase activity
- phosphatidic acid binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NME3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NME3 as an antibody target. Whether an autoantibody or antibody against NME3 could matter depends on whether native NME3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NME3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NME3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...